Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetaminophen and Morphine in Experimental Pain Models
NCT02678416Phase 4Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Dec 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acetaminophen in pain (4 arms), sponsored by Mallinckrodt Pharmaceuticals. Primary endpoint: Part 1: Change From Baseline in Pain Intensity at Hour 6 Using the Thermal Suprathreshold Pain in the Ultraviolet-B (UVB) Burn Pain Model. Started Dec 2015; status: completed.
02
Drugs
acetaminophen
03
Conditions
pain
Beyond the preview
Go deeper on NCT02678416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678416.